NEBRASKA METHODIST HOSPITAL

HEART DISEASE AND STROKEON AVERAGE, SOMEONE IN THE UNITED STATES DIES OF CARDIOVASCULAR DISEASE EVERY 34 SECONDS, ACCORDING TO THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR DISEASE.METHODIST HOSPITAL HAS BEEN A LEADER IN THE CARE AND TREATMENT OF THOSE WHO COME TO US IN OUR EMERGENCY DEPARTMENT OR ARE DIAGNOSED WITH CARDIOVASCULAR DISEASE. WE HAVE LONG BEEN AT THE FOREFRONT IN CARING FOR THESE PATIENTS AND ARE ALWAYS EXPLORING WAYS TO ENHANCE THEIR TREATMENT AND LIFESTYLE.METHODIST HOSPITAL'S COMMITMENT AND SUCCESS IN IMPLEMENTING AN EXCEPTIONAL STANDARD OF CARE FOR CARDIAC PATIENTS HAS BEEN RECOGNIZED BY THE AMERICAN HEART ASSOCIATION AND THE JOINT COMMISSION.2023 ACCOMPLISHMENTS IN THE CARDIOLOGY AREA INCLUDED THE FOLLOWING:THE AMERICAN HEART ASSOCIATION (AHA) RECOGNIZED METHODIST HOSPITAL WITH TWO MISSION: LIFELINE AWARDS FOR ITS COMMITMENT TO OFFERING RAPID RESEARCH-BASED CARE TO PEOPLE EXPERIENCING TWO SPECIFIC TYPES OF HEART ATTACKS. METHODIST HOSPITAL RECEIVED THE MISSION: LIFELINE STEMI RECEIVING GOLD PLUS AWARD AND THE MISSION: LIFELINE NSTEMI SILVER AWARD. THESE AWARDS ARE DESIGNED TO SHOWCASE HOSPITALS THAT PROVIDE 24/7 SUPPORT FOR HEART ATTACKS AND COORDINATE WITH A NETWORK OF REFERRING HOSPITALS AND EMERGENCY MEDICAL SERVICES TO PROVIDE GUIDELINE-DIRECTED STEMI AND NSTEMI CARE.BY ACHIEVING INTERSOCIETAL ACCREDITATION COMMISSION (IAC) ECHOCARDIOGRAPHY ACCREDITATION FOR 20 YEARS, METHODIST HOSPITAL RECEIVED BRONZE MILESTONE RECOGNITION FOR DEMONSTRATING LONG-TERM COMMITMENT TO CONTINUOUSLY IMPROVING PATIENT OUTCOMES AND SAFETY. EVERY THREE-YEAR CYCLE, ACCREDITED FACILITIES UNDERGO AN INTENSIVE APPLICATION AND REVIEW PROCESS TO RE-EARN ACCREDITATION, WITH AN ASSESSMENT CONDUCTED BY A PANEL OF MEDICAL EXPERTS.THE METHODIST HOSPITAL CARDIOLOGY TEAM COMPLETED ITS 1,000TH WATCHMAN PROCEDURE ON JULY 10. METHODIST'S IS THE FIRST PROGRAM IN NEBRASKA, SECOND IN THE REGION AND 27TH NATIONALLY TO REACH THE 1,000-PROCEDURE MARK.METHODIST HOSPITAL RECEIVED A THREE-STAR RATING FROM THE SOCIETY OF THORACIC SURGEONS (STS) FOR ITS PATIENT CARE AND OUTCOMES IN ISOLATED CORONARY ARTERY BYPASS GRAFTING (CABG) PROCEDURES. THE THREE-STAR RATING, WHICH DENOTES THE HIGHEST CATEGORY OF QUALITY, PLACES THE HOSPITAL AMONG THE ELITE FOR HEART BYPASS SURGERY IN THE UNITED STATES AND CANADA. THE VASCULAR TEAM AT METHODIST TREATED THEIR 100TH PATIENT WITH HYBRID AF THERAPY (CONVERGENT). METHODIST CONTINUES TO BE NAMED AS ONE OF THE TOP 5 OF 225 PROGRAMS NATIONWIDE, THREE YEARS RUNNING.METHODIST WAS THE TOP ENROLLING SITE GLOBALLY WITH NINE OF THE FIRST 51 PATIENTS IN THE HI-PEITHO TRIAL, WHICH IS A RESEARCH STUDY FOCUSED ON THE TREATMENT OF PULMONARY EMBOLISMS. METHODIST HOSPITAL EARNED THE MISSION: LIFELINE STEMI RECEIVING SILVER PLUS AWARD FROM THE AMERICAN HEART ASSOCIATION.

CANCERAT METHODIST HOSPITAL, WE UNITE ALL OF OUR RESOURCES TO JOIN OUR PATIENTS IN THEIR FIGHT AGAINST CANCER IN ITS TOTALITY. OUR UNIQUE MULTIDISCIPLINARY APPROACH IS ONE OF METHODIST'S GREATEST STRENGTHS. WORKING TOGETHER WITH THE PATIENT ON THE TEAM, WE FOCUS A RARE LEVEL OF COMBINED EXPERTISE TO EXPAND TREATMENT OPTIONS, IMPROVE OUTCOMES AND PROVIDE COMFORT AND HOPE.WE OFFER A FULL LINE OF CANCER SERVICES AT METHODIST ESTABROOK CANCER CENTER (MECC) INCLUDING: BREAST CARE CENTER, CHEMOTHERAPY, CLINICAL TRIALS, GAMMA KNIFE, GYNECOLOGIC ONCOLOGY, HEAD AND NECK ONCOLOGY, LUNG/THORACIC ONCOLOGY, MULTIDISCIPLINARY TEAM APPROACH, NUTRITION SERVICES, OCCUPATIONAL AND SPEECH THERAPY, PHYSICAL WELLNESS PROGRAMS, PSYCHO-ONCOLOGY SERVICES, RADIATION ONCOLOGY, REHABILITATION, SOCIAL WORK, STEM CELL TRANSPLANTS, SUPPORT SERVICES, SURGICAL ONCOLOGY AND TUMOR REGISTRY.OUR HIGHLY SKILLED TEAM OF EXPERTS USES SOME OF THE MOST ADVANCED DIAGNOSTIC AND TREATMENT OPTIONS AVAILABLE TO HELP OUR PATIENTS CONQUER THEIR CANCER DIAGNOSIS. THOSE OPTIONS INCLUDE, BUT ARE NOT LIMITED TO: DA VINCI COMPUTER-ASSISTED SURGICAL SYSTEM, DIGITAL POSITRON EMISSION TOMOGRAPHY/COMPUTER TOMOGRAPHY (PET/CT) SYSTEM, IMAGE-GUIDED RADIATION THERAPY (IGRT), VOLUMETRIC-MODULATED ARC THERAPY (VMAT), VARIAN EDGE RADIOSURGERY SYSTEM AND SPY PORTABLE HANDHELD IMAGER (SPY-PHI).CANCER SCREENINGS CONTINUE TO BE OUR FIRST LINE OF ATTACK WORKING TO CATCH CANCERS EARLY. OUR MOBILE MAMMOGRAPHY COACH WAS ON THE ROAD A GREAT DEAL IN 2023, AS WE PERFORMED 2,928 MAMMOGRAM SCREENINGS, 518 WERE BASELINE, MEANING A FIRST-TIME SCREENING. OF THOSE NEARLY 3,000 SCREENINGS, 44 WOMEN WERE RECOMMENDED FOR BIOPSIES AND 12 POSITIVE CANCERS WERE DETECTED. IN ADDITION, THE MECC TEAM PERFORMED OVER 5,000 CANCER PREVENTION SCREENINGS IN 2023. OF THE 5,204 SCREENINGS PERFORMED 472 REQUIRED FOLLOW-UP. THIS INCLUDES HEAD & NECK SCREENINGS, COLON CANCER SCREENINGS, LOW DOSE CTS AND COMMUNITY EVENTS (LIKE BINATIONAL HEALTH WEEK) IN AN EFFORT TO CONTINUE TO MEET PATIENTS WHERE THEY ARE, RADIATION ONCOLOGY PHYSICIAN SERVICES EXPANDED TO METHODIST FREMONT HEALTH, COMPLETING A COMMON PLATFORM ACROSS THE HEALTH SYSTEM.LAUNCHED CAR T THERAPY - A SPECIFIC TYPE OF IMMUNOTHERAPY USING T CELLS FROM THE PATIENT, WHICH BECOME REENGINEERED INTO CANCER-FIGHTING CAR (CHIMERIC ANTIGEN RECEPTOR) T CELLS.THE AMERICAN CANCER SOCIETY RENEWED A GRANT TO METHODIST HOSPITAL ALLOWING IT TO ADDRESS THE UNMET TRANSPORTATION NEEDS OF CANCER PATIENTS IN THE REGION, PARTICULARLY VULNERABLE POPULATIONS WHO ARE EXPERIENCING AN UNEQUAL BURDEN OF CANCER. THE GRANTS ARE AVAILABLE TO HEALTH SYSTEMS, TREATMENT CENTERS AND COMMUNITY ORGANIZATIONS IN SELECT COMMUNITIES THROUGH AN APPLICATION PROCESS. THEY FOCUS ON ADDRESSING THE UNMET TRANSPORTATION NEEDS OF CANCER PATIENTS, PARTICULARLY VULNERABLE POPULATIONS EXPERIENCING AN UNEQUAL BURDEN OF CANCER. MECC HAS BEEN DESIGNATED AS A CARE CONTINUUM CENTER OF EXCELLENCE BY GO2 FOUNDATION FOR LUNG CANCER (GO2 FOUNDATION). METHODIST HOSPITAL JOINS MORE THAN 60 OTHER COMMUNITY HOSPITALS AND WAS THE FIRST IN NEBRASKA TO BE HONORED WITH THE DESIGNATION, WHICH RECOGNIZES COMMITMENT TO IMPROVING OUTCOMES FOR THOSE DIAGNOSED WITH LUNG CANCER BY PROVIDING PATIENT-FOCUSED AND COORDINATED MULTIDISCIPLINARY CARE. MECC IS ALSO NATIONALLY RECOGNIZED AS AN APPROVED NPF PANCREATIC CANCER CENTER BY THE NATIONAL PANCREAS FOUNDATION. MECC IS THE ONLY NPF CENTER SERVING PATIENTS IN NEBRASKA AND IOWA, AND IT'S ONE OF FEWER THAN 70 NPF CENTERS NATIONWIDE. WE ARE ALSO ACCREDITED BY THE FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY (FACT) AT THE UNIVERSITY OF NEBRASKA MEDICAL CENTER. IN ADDITION TO PROVIDING THE STANDARD TREATMENTS, THE PHYSICIANS AT METHODIST HOSPITAL AND MECC HAVE CONSISTENTLY DEMONSTRATED ACTIVE PARTICIPATION IN CANCER PREVENTION AND TREATMENT TRIALS APPROVED BY THE NATIONAL CANCER INSTITUTE (NCI). EVERY CANCER PATIENT TREATED HERE IS EVALUATED FOR ELIGIBILITY IN NCI-APPROVED TRIALS, AND TRIAL PARTICIPATION IS ENTIRELY VOLUNTARY. ONLY ABOUT 3-5% PERCENT OF ADULT CANCER PATIENTS NATIONWIDE PARTICIPATE IN CLINICAL TRIALS, ACCORDING TO THE NCI. MECC EXCEEDS THAT ON A REGULAR BASIS. OUR CLINICAL TRIALS ARE OVERSEEN BY A HIGHLY TRAINED, MULTIDISCIPLINARY TEAM OF CANCER SPECIALISTS IN COLLABORATION WITH THE PATIENT'S PRIMARY CARE PROVIDER.